Rectan Express Transparant

Hazard statements (CLP)

H315, H317, H319, H332, H334, H335, H351, H373

Code

Statements

H315

Causes skin irritation

SECTION 2: Hazards identification

According to Regulation (EC) No. 1272/2008 (CLP) Classification of the substance or mixture

Adverse physicochemical, human health and environmental effects

Suspected of causing cancer. May cause damage to organs through prolonged or repeated exposure. Harmful if inhaled. May cause respiratory irritation. Causes skin irritation. May cause an allergic skin reaction. Causes serious eye irritation. May cause allergy or asthma symptoms or breathing difficulties if inhaled

Hazard pictograms

GHS07 GHS08

Signal word

Danger

Contains

methylenediphenyl diisocyanate

Hazard statements

H315 - Causes skin irritation. H317 - May cause an allergic skin reaction. H319 - Causes serious eye irritation. H332 - Harmful if inhaled. H334 - May cause allergy or asthma symptoms or breathing difficulties if inhaled. H335 - May cause respiratory irritation. H351 - Suspected of causing cancer. H373 - May cause damage to organs through prolonged or repeated exposure.

Precautionary statements

P101 - If medical advice is needed, have product container or label at hand. P102 - Keep out of reach of children. P261 - Avoid breathing vapours, mist. P280 - Wear protective gloves, protective clothing, eye protection, face protection. P304+P340 - IF INHALED: Remove person to fresh air and keep comfortable for breathing. P308+P313 - IF exposed or concerned: Get medical advice/attention. P405 - Store locked up. P501 - Dispose of contents, container to hazardous or special waste collection point, in accordance with local, regional, national and/or international regulation.

Additional information

Persons already sensitised to diisocyanates may develop allergic reactions when using this product. Persons suffering from asthma, eczema or skin problems should avoid contact, including dermal contact, with this product. This product should not be used under conditions of poor ventilation unless a protective mask with an appropriate gas filter (i.e. type A1 according to standard EN 14387) is used. As from 24 August 2023 adequate training is required before industrial or professional use.

2.3 Other hazards

Contains no PBT/vPvB substances ≥ 0.1% assessed in accordance with REACH Annex XIII The mixture does not contain substance(s) included in the list established in accordance with Article 59(1) of REACH for having endocrine disrupting properties, or is not identified as having endocrine disrupting properties in accordance with the criteria set out in Commission Delegated Regulation (EU) 2017/2100 or Commission Regulation (EU) 2018/605 at a concentration equal to or greater than 0,1 %

2.1 Classification of the substance or mixture

Classification according to Regulation (EC) No. 1272/2008 [CLP] Acute toxicity (inhalation:dust,mist) Category 4 H332 Skin corrosion/irritation, Category 2 H315 Serious eye damage/eye irritation, Category 2 H319 Respiratory sensitisation, Category 1 H334 Skin sensitisation, Category 1 H317 Carcinogenicity, Category 2 H351 Specific target organ toxicity – Single exposure, Category 3, Respiratory H335 tract irritation Specific target organ toxicity – Repeated exposure, Category 2 H373 Full text of H- and EUH-statements: see section 16 Adverse physicochemical, human health and environmental effects Suspected of causing cancer. May cause damage to organs through prolonged or repeated exposure. Harmful if inhaled. May cause respiratory irritation. Causes skin irritation. May cause an allergic skin reaction. Causes serious eye irritation. May cause allergy or asthma symptoms or breathing difficulties if inhaled.